Durkan welcomes approval of pancreatic cancer drug

Thu, 26/10/2017 - 14:55 -- Editor

Subscribe to NewswireNI

From just 20p

Already a newswire subscriber? Log in here

Mark H Durkan has welcomed health board approval for Abraxane, which can extend the life of pancreatic cancer sufferers by 3 years